Nobuhiro Kanaji
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation.
Journal: Respirology (Carlton, Vic.)
Published: September 06, 2025
Promising Effectiveness of Combined Chemotherapy and Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Real-World Prospective Observational Study (CS-Lung-003).
Journal: Acta medica Okayama
Published: June 27, 2025
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for EGFR L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis.
Journal: JTO clinical and research reports
Published: June 16, 2025
Torso FDG-PET parameters as prognostic biomarkers for advanced non-small cell lung cancer patients undergoing first-line immunotherapy and chemotherapy.
Journal: BMC cancer
Published: May 22, 2025
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry study.
Journal: Respiratory investigation
Published: April 02, 2025
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004).
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 15, 2025
Expert consensus on cancer treatment-related lung injury.
Journal: Journal of thoracic disease
Published: February 12, 2025
Palliative surgery is effective in patients with EGFR-mutant lung adenocarcinoma with pleural metastasis.
Journal: Translational lung cancer research
Published: February 08, 2025
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).
Journal: Therapeutic advances in medical oncology
Published: February 07, 2025
Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease.
Journal: Journal of personalized medicine
Published: December 25, 2024
Prevalence and clinical features of interstitial lung disease in patients with psoriasis.
Journal: BMC pulmonary medicine
Published: August 30, 2024
Last Updated: 09/26/2026